Previous close | 36.20 |
Open | 36.20 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 55.00 |
Expiry date | 2025-01-17 |
Day's range | 36.20 - 36.20 |
Contract range | N/A |
Volume | |
Open interest | 67 |
Investing.com -- U.S. stock futures edged higher Monday, starting the holiday-shortened week on a positive note ahead of the release of key unemployment data.
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the U.S. National Institutes of Health (NIH). Hoau-Yan Wang was a tenured medical professor at a public university’s medical school as well as a former paid science advisor to Cassava Sciences. According to public court documents, Dr. Wang engaged in illegal behavior to defraud the go